The Nucleotide Sequence of a Type 3 Poliovirus Isolated During a Recent Outbreak of Poliomyelitis in Finland Free

Abstract

Summary

We have cloned and sequenced the complete genome of a strain of poliovirus type 3 (23127) isolated during an outbreak of poliomyelitis in Finland. The genome is 7435 nucleotides long excluding the 3′ poly(A) stretch and is 95.5% homologous at the amino acid level to the previously sequenced type 3 strain, P3/Leon/37. The most striking feature of the presented sequence is the extent of amino acid substitutions relative to P3/Leon/37 and other type 3 strains in areas of known antigenic importance. The major antigenic determinant for virus neutralization (site 1), located at residues 89 to 100 of VP1, has three amino acid substitutions and there are six substitutions in site 3, a composite site made up of sequences from VP1 and VP3. The variation in these regions probably accounts for the observed unusual antigenicity and may explain why the virus was able to spread in a well-vaccinated community. Sequence comparisons imply that the virus is not derived from the currently used live attenuated vaccine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-67-10-2093
1986-10-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/67/10/JV0670102093.html?itemId=/content/journal/jgv/10.1099/0022-1317-67-10-2093&mimeType=html&fmt=ahah

References

  1. Cann A. J., Stanway G., Hauptmann R., Minor P. D., Schild G. C., Clarke L. D., Mountford R. C., Almond J. W. 1983; Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteins. Nucleic Acids Research 11:1267–1281
    [Google Scholar]
  2. Domingo E., Martinez-Salas E., Sobrino F., De La Torre I. C., Portela A., Ortin J., Lopez-Galindez C., Perez-brena P., Villanueva N., Najera R., Vandepol S., Steinhauer D., Depolo N., Holland J. 1985; The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance - a review. Gene 40:1–8
    [Google Scholar]
  3. Evans D. M. A., Minor P. D., Schild G. C., Almond J. W. 1983; Critical role of an eight amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature, London 304:459–462
    [Google Scholar]
  4. Ferguson M., Evans D. M. A., Magrath D. I., Minor P. D., Almond J. W., Schild G. C. 1985; Induction of broadly reactive, type specific neutralizing antibody to poliovirus type 3 by synthetic peptides. Virology 143:505–515
    [Google Scholar]
  5. Hogle J. M., Chow M., Filman D. J. 1985; The three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229:1358–1365
    [Google Scholar]
  6. Kew O. M., Nottay B. K. 1985; Evolution of the oral polio vaccine strains in humans occurs by both mutation and intermolecular recombination. In Modern Approaches to Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunogenicity pp 357–362 Edited by Chanock R. M., Lemer R. A. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  7. Kitamura N., Semler B., Rothberg P. G., Larsen G. R., Adler C. J., Dorner A. J., Emini E. A., Hanecak R., Lee I. J., Van Der Werf S., Anderson C. W., Wimmer E. 1981; Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature, London 291:547–553
    [Google Scholar]
  8. Lapinlemu K., Stenvik M. 1981; Experience with polio vaccination and herd immunity in Finland. Developments in Biological Standardization 47:241–246
    [Google Scholar]
  9. Magrath D. I., Evans D. M. A., Ferguson M., Schild G. C., Minor P. D., Horaud F., Crainic R., Stenvik M., Hovi T. 1986; Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population. Journal of General Virology 67:899–905
    [Google Scholar]
  10. Minor P. D., Ferguson M., Evans D. M. A., Almond J. W., Icenogle J. P. 1986b; Antigenic structure of polioviruses of serotypes 1, 2 and 3. Journal of General Virology 67:1283–1291
    [Google Scholar]
  11. Staden R. 1980; A new computer method for the storage and manipulation of DNA gel reading data. Nucleic Acids Research 8:3673–3694
    [Google Scholar]
  12. Stanway G., Cann A. J., Hauptmann R., Hughes P., Clarke L. D., Mountford R. C., Minor P. D., Schild G. C., Almond J. W. 1983; The nucleotide sequence of poliovirus type 3 Leon 12a1, b: comparison with poliovirus type 1. Nucleic Acids Research 11:5629–5643
    [Google Scholar]
  13. Stanway G., Mountford R. C., Cox S. D. J., Schild G. C., Minor P. D., Almond J. W. 1984a; Molecular cloning of the genomes of poliovirus type 3 strains by the cDNA : RNA hybrid method. Archives of Virology 81:67–78
    [Google Scholar]
  14. Stanway G., Hughes P. J., Mountford R. C., Reeve P., Minor P. D., Schild G. C., Almond J. W. 1984b; Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1 b. Proceedings of the National Academy of Sciences, U.S.A. 81:1539–1543
    [Google Scholar]
  15. Stanway G., Hughes P. J., Mountford R. C., Minor P. D., Almond J. W. 1984c; The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Research 12:7859–7875
    [Google Scholar]
  16. Toyoda H., Kohara M., Kataoka Y., Suganuma T., Omata T., Imura N., Nomoto A. 1984; Complete nucleotide sequences of all three poliovirus serotype genomes: implication for genetic relationship, gene function and antigenic determinants. Journal of Molecular Biology 174:561–585
    [Google Scholar]
  17. Weekly Epidemiological Record 1985; 2:11
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-67-10-2093
Loading
/content/journal/jgv/10.1099/0022-1317-67-10-2093
Loading

Data & Media loading...

Most cited Most Cited RSS feed